BlackRock Investment Management, LLC - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 38 filers reported holding PSYCHEMEDICS CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q4 2016$22,000
+29.4%
8770.0%0.00%
Q3 2016$17,000
+41.7%
8770.0%0.00%
Q2 2016$12,000
-7.7%
877
-8.5%
0.00%
Q1 2016$13,000
+30.0%
9580.0%0.00%
Q4 2015$10,000
+11.1%
958
+9.6%
0.00%
Q3 2015$9,000
-30.8%
8740.0%0.00%
Q2 2015$13,000
-13.3%
874
-4.9%
0.00%
Q1 2015$15,000
+7.1%
9190.0%0.00%
Q4 2014$14,000
+7.7%
9190.0%0.00%
Q3 2014$13,0000.0%9190.0%0.00%
Q2 2014$13,0009190.00%
Other shareholders
PSYCHEMEDICS CORP shareholders Q2 2015
NameSharesValueWeighting ↓
Tieton Capital Management, LLC 301,282$4,227,0003.76%
QUANTUM CAPITAL MANAGEMENT 56,179$788,0000.42%
Mill Road Capital Management LLC 14,896$209,0000.27%
Gs Investments, Inc. 15,300$214,659,0000.17%
North Star Investment Management Corp. 84,948$1,192,0000.14%
CRAWFORD INVESTMENT COUNSEL INC 310,870$4,362,0000.13%
RBF Capital, LLC 78,495$1,101,0000.13%
Uniplan Investment Counsel, Inc. 123,339$1,730,0000.11%
DEPRINCE RACE & ZOLLO INC 274,416$3,850,0000.10%
KENNEDY CAPITAL MANAGEMENT LLC 446,074$6,258,0000.07%
View complete list of PSYCHEMEDICS CORP shareholders